Best Non-Hodgkin's lymphoma Doctors in Israel — TOP 20

Dr. Ram Ron is the Director of the Bone Marrow Transplantation Unit at Sourasky Medical Center's onco-hematology department.

• Trained at the renowned Fred Hutchinson Cancer Research Center in the United States
• Specializes in hematology and bone marrow transplantation for blood cancers
• Board-certified in internal medicine, hematology, and bone marrow transplantation
• Over a decade of clinical experience in major Israeli hematology institutes

Dr. Ron Ram has performed several hundred stem cell transplants, a key treatment for Non-Hodgkin's lymphoma, at Sourasky Medical Center (Ichilov).

• Board-certified in Hematology, Medical Oncology, and Internal Medicine
• Authored over 30 scientific articles and a textbook chapter on the field
• Completed a Hematology and Oncology fellowship at New York Medical College
• Residency training at the State University of New York at Brooklyn

Dr. El Hasid has performed over 300 bone marrow and umbilical cord blood transplants for children, heading the department at Dana Dwek Children's Hospital.

• Specializes exclusively in pediatric oncohematology and oncology
• Author of 50 scientific publications and 40 conference reports
• Member of the American Society of Hematology
• Trained and practiced at the prestigious City of Hope Hospital in Los Angeles
• Member of the Israeli Society for Pediatric Hemato-Oncology

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

A senior bone marrow transplantation specialist for Non-Hodgkin's lymphoma, Dr. Shapira is trained at one of Israel's leading centers.

• Over 36 years of experience of experience in hematology
• Specialized in internal medicine at Hadassah Medical Center
• Senior physician in the Bone Marrow Transplantation department
• Focuses on this complex treatment approach

36 years of experience at Memorial Sloan Kettering Cancer Center – Dr. Joffe specializes in lymphoma and CLL treatment at Sourasky Medical Center.

• Advanced subspecialty training in lymphomas and CLL
• Managed clinical studies in new drugs and immunotherapy
• Member of rare lymphoma treatment physician groups
• Senior doctor in Hematology and Bone Marrow Transplantation

With 34 years of experience focused on oncohematology, Dr. Aviv brings deep expertise in treating Non-Hodgkin's lymphoma at Ichilov Clinic.

• Specializes in blood cancers and complex hematologic conditions
• Works at Sourasky Medical Center – a leading oncology hospital
• Dedicated to personalized treatment approaches for each patient

Dr. Dror Levin directs the children's hematology oncology department at Sourasky Medical Center – a leading expert in pediatric blood disorders.

• Specializes in treating bone and soft tissue cancers (sarcomas) in children
• Board-certified in pediatric hematology and oncology
• Trained at Rizzoli Orthopaedic Institute – a world leader in bone oncology
• Member of the Israeli Society of Pediatric Hematology-Oncology
• Coordinates treatment programs for clotting disorders in children

Dr. Yair has made significant contributions to hematology, particularly in chronic lymphocytic leukemia, with numerous awards and published research.

• Recipient of multiple prestigious awards, including the Young Investigator Research Prize and Klitzberg Oncology Award
• Member of both the Israeli and American Hematology Associations
• Extensive training in hematology at Tel Aviv Medical Center
• Published researcher with grants from the Israeli Science Foundation and others

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Ofer Spielberg is an oncologist specializing in Non-Hodgkin's lymphoma at Assuta Medical Center.

• Focuses on advanced diagnostic methods and tailored treatment protocols
• Integrates latest clinical research into surgical practice
• Available to advise on both routine and complex lymphoma cases

Recognized by Forbes as one of the best doctors in 2018 – Dr. Stepensky has performed over 3,500 bone marrow transplants at Hadassah Medical Center.

• 28 years of experience of experience in pediatric hematology
• Specializes in treating children with rare blood cancers
• Known among patients as 'the one who transplants life'
• Works at Hadassah Medical Center – a leading Israeli hospital

Professor Zila Zuckerman specializes in hematology and transplantology at Rambam Medical Center.

• Expertise in Non-Hodgkin's lymphoma treatment
• Specializes in hematology and transplantology
• Works at Rambam Medical Center

Specializes exclusively in hematology with a focus on treating lymphomas. He practices at Rambam Medical Center – a leading Israeli hospital.

• Offers a dedicated focus on the complex care lymphoma requires
• Possesses in-depth knowledge of lymphoma-specific treatments and protocols
• His hematology specialization ensures up-to-date care for blood cancers